Back to Search
ROBERT MILLET, M.D.
M.D.
Psychiatry Physician
NPI: 1134168347IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
36397(NC)
CMS Specialties
PrimaryPSYCHIATRY
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 1991
Research & Publications (13)
Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.
PMID 16250662·J Med Chem·2005
7-preclinical
Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides.
PMID 12443785·Bioorg Med Chem Lett·2002
7-preclinical
Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives.
PMID 12110311·Bioorg Med Chem·2002
7-preclinical
A flexible approach to the design of new potent substance P receptor ligands.
PMID 11480541·J Pharm Pharmacol·2001
7-preclinical
Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor.
PMID 11461046·J Pept Sci·2001
7-preclinical
Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
PMID 17915849·J Med Chem·2007
7-preclinical
Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.
PMID 17827015·Bioorg Med Chem Lett·2007
7-preclinical
Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
PMID 16647166·Eur J Med Chem·2006
8-other
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
PMID 16392793·J Med Chem·2006
8-other
Synthesis of a novel conformationally restricted Val-Phe dipeptidomimetic.
PMID 15948143·J Pept Sci·2006
8-other
In vitro and in vivo evaluation of two rational-designed nonpeptidic farnesyltransferase inhibitors on HT29 human colon cancer cell lines.
PMID 16925112·Oncol Res·2005
7-preclinical
Novel N-(4-Piperidinyl)benzamide antimalarials with mammalian protein farnesyltransferase inhibitory activity.
PMID 16204993·Chem Pharm Bull (Tokyo)·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7850 BRIER CREEK PKWY
RALEIGH, NC 27617 - Phone
- (191) 748-4878
Quick Facts
- NPI
- 1134168347
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 13
Are you this provider?
Claim Your Profile